Cargando…
A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study
Occasional rhinitis symptoms caused by exposure to pollution or allergens is a growing concern. Based first on empirical observation of a lesser occurrence of allergies in quail farmers and then scientific works on ovomucoids properties, we developed a dietary supplement for the relief of such occas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256569/ https://www.ncbi.nlm.nih.gov/pubmed/25493182 http://dx.doi.org/10.1002/fsn3.147 |
_version_ | 1782347604107984896 |
---|---|
author | Benichou, Annie-Claude Armanet, Marion Bussière, Anthony Chevreau, Nathalie Cardot, Jean-Michel Tétard, Jan |
author_facet | Benichou, Annie-Claude Armanet, Marion Bussière, Anthony Chevreau, Nathalie Cardot, Jean-Michel Tétard, Jan |
author_sort | Benichou, Annie-Claude |
collection | PubMed |
description | Occasional rhinitis symptoms caused by exposure to pollution or allergens is a growing concern. Based first on empirical observation of a lesser occurrence of allergies in quail farmers and then scientific works on ovomucoids properties, we developed a dietary supplement for the relief of such occasional rhinitis symptoms. The objective of the study was to determine whether one acute oral dose of the study product attenuates nasal provocation and other allergy-related symptoms after exposure to a standardized allergenic challenge as compared to placebo. Healthy subjects were recruited to participate in a randomized, double-blind, two-arm crossover, placebo-controlled, clinical trial. One acute dose of either the active study product (proprietary blend of quail egg) or placebo was given concomitantly to the standardized allergenic challenge. The primary endpoint was peak nasal inspiratory flow (PNIF) measurement and the secondary endpoints were subjects' perceived feelings of well-being based on Visual Analog Scale (VAS) scores for allergy-related symptoms, as well as immunoglobulin E count. Forty-three healthy subjects were enrolled and evaluable in a per protocol analysis. A gradual increase in PNIF from nadir up to Time 120 reflected the normal, gradual recovery from nasal obstruction induced by allergenic challenge for both the active and the placebo groups. At all postchallenge time points, the active group had higher PNIF values compared to the placebo group, indicating that the active product was associated with fewer symptoms and reduced intensity of these symptoms. The active product resulted also in statistically significant improvements of most of the subjects' perceived feelings of well-being based on VAS scores. No adverse events occurred during the study. In conclusion, the dietary supplement consisting of proprietary blend made of quail eggs provides fast and efficient relief of allergic rhinitis symptoms caused by the most common outdoor and indoor allergens, without adverse events. |
format | Online Article Text |
id | pubmed-4256569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42565692014-12-09 A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study Benichou, Annie-Claude Armanet, Marion Bussière, Anthony Chevreau, Nathalie Cardot, Jean-Michel Tétard, Jan Food Sci Nutr Original Research Occasional rhinitis symptoms caused by exposure to pollution or allergens is a growing concern. Based first on empirical observation of a lesser occurrence of allergies in quail farmers and then scientific works on ovomucoids properties, we developed a dietary supplement for the relief of such occasional rhinitis symptoms. The objective of the study was to determine whether one acute oral dose of the study product attenuates nasal provocation and other allergy-related symptoms after exposure to a standardized allergenic challenge as compared to placebo. Healthy subjects were recruited to participate in a randomized, double-blind, two-arm crossover, placebo-controlled, clinical trial. One acute dose of either the active study product (proprietary blend of quail egg) or placebo was given concomitantly to the standardized allergenic challenge. The primary endpoint was peak nasal inspiratory flow (PNIF) measurement and the secondary endpoints were subjects' perceived feelings of well-being based on Visual Analog Scale (VAS) scores for allergy-related symptoms, as well as immunoglobulin E count. Forty-three healthy subjects were enrolled and evaluable in a per protocol analysis. A gradual increase in PNIF from nadir up to Time 120 reflected the normal, gradual recovery from nasal obstruction induced by allergenic challenge for both the active and the placebo groups. At all postchallenge time points, the active group had higher PNIF values compared to the placebo group, indicating that the active product was associated with fewer symptoms and reduced intensity of these symptoms. The active product resulted also in statistically significant improvements of most of the subjects' perceived feelings of well-being based on VAS scores. No adverse events occurred during the study. In conclusion, the dietary supplement consisting of proprietary blend made of quail eggs provides fast and efficient relief of allergic rhinitis symptoms caused by the most common outdoor and indoor allergens, without adverse events. BlackWell Publishing Ltd 2014-11 2014-07-20 /pmc/articles/PMC4256569/ /pubmed/25493182 http://dx.doi.org/10.1002/fsn3.147 Text en © 2014 Stragen Pharma S.A.Food Science & Nutrition published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Benichou, Annie-Claude Armanet, Marion Bussière, Anthony Chevreau, Nathalie Cardot, Jean-Michel Tétard, Jan A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title | A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title_full | A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title_fullStr | A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title_full_unstemmed | A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title_short | A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
title_sort | proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256569/ https://www.ncbi.nlm.nih.gov/pubmed/25493182 http://dx.doi.org/10.1002/fsn3.147 |
work_keys_str_mv | AT benichouannieclaude aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT armanetmarion aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT bussiereanthony aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT chevreaunathalie aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT cardotjeanmichel aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT tetardjan aproprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT benichouannieclaude proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT armanetmarion proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT bussiereanthony proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT chevreaunathalie proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT cardotjeanmichel proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy AT tetardjan proprietaryblendofquaileggfortheattenuationofnasalprovocationwithastandardizedallergenicchallengearandomizeddoubleblindplacebocontrolledstudy |